Brain stem glioma – Life with Disease

Go back

Brain stem glioma is a type of tumor that develops in the brainstem, the vital area that connects the brain to the spinal cord and controls essential functions like breathing, heart rate, and balance. These tumors can affect both children and adults, though they appear more frequently in younger patients, and they vary greatly in how they grow and respond to treatment.

Understanding Prognosis and Survival Outlook

When someone receives a diagnosis of brain stem glioma, one of the most pressing questions concerns what the future holds. The prognosis for brain stem glioma depends heavily on several factors, including the type of tumor, its grade, its exact location within the brainstem, and the age of the patient. Understanding these factors can help patients and families prepare emotionally and practically for the journey ahead.[1]

For patients with focal brainstem gliomas—which grow slowly and remain in one specific area—the outlook tends to be more favorable. These tumors, usually found in the midbrain or medulla, are often low-grade and easier to treat. When surgeons can remove most or all of the visible tumor, survival can extend for many years, and some patients may even be cured. Radiation therapy following surgery can also be highly effective in controlling any remaining tumor cells.[1]

The situation is more challenging for patients diagnosed with diffuse intrinsic pontine glioma (DIPG), a grade IV tumor that grows rapidly within the pons, the middle section of the brainstem. This type of brainstem glioma is extremely aggressive and tends to spread throughout the brainstem and into neighboring structures. For children with DIPG, survival time is often less than 18 months despite treatment efforts. Most children with focal gliomas, on the other hand, survive more than 18 months.[9]

In adults, brainstem gliomas are much rarer, accounting for less than 2 percent of all gliomas in people over the age of 16. However, when they do occur in adults, these tumors tend to be less aggressive and carry a better prognosis than those in children. Current data suggests that adults diagnosed with brainstem glioma have an average survival time of approximately 44 to 74 months following diagnosis, which is significantly longer than what is typically seen in pediatric cases.[3][26]

⚠️ Important
Survival statistics represent averages across many patients and cannot predict an individual’s exact outcome. Each person’s tumor has unique characteristics, and ongoing advances in treatment are continually improving outcomes. Every day, researchers discover new therapies and refine existing approaches, offering renewed hope for patients diagnosed with brainstem glioma.

The increasing tumor grade is associated with poorer prognosis. Grade 1 tumors, classified as juvenile pilocytic astrocytoma, generally have the best outcomes. Grade 4 tumors, or glioblastoma, carry the most serious prognosis due to their rapid growth and tendency to invade surrounding tissue. The presence of certain features such as necrosis, vascular proliferation, and nuclear abnormalities under the microscope helps doctors determine the grade and expected behavior of the tumor.[3]

It’s also important to note that molecular profiling has become an essential part of understanding glioma prognosis. Certain genetic mutations can significantly influence how a tumor behaves and responds to treatment. For example, an IDH1 mutation is associated with a significantly improved prognosis compared to tumors without this mutation, regardless of the tumor’s grade. This molecular information helps doctors tailor treatment plans more precisely to each patient’s unique situation.[3]

Natural Progression of the Disease

If left untreated, brain stem glioma follows a progressive course that varies depending on the tumor type and grade. Understanding how these tumors naturally develop helps patients and families appreciate the importance of timely intervention and ongoing monitoring.

Low-grade focal brainstem gliomas grow slowly over months or even years. Without treatment, these tumors gradually expand within the brainstem, pressing on vital structures and increasingly interfering with the functions controlled by that region of the brain. The symptoms typically worsen gradually, giving patients and doctors time to consider treatment options carefully. Some focal gliomas may remain stable for extended periods, growing so slowly that they cause minimal symptoms for a long time.[7]

High-grade brainstem gliomas, particularly DIPG, progress much more rapidly. These tumors can develop symptoms over just days or weeks rather than months. The tumor cells invade and infiltrate throughout the brainstem, spreading like roots through the tissue rather than forming a distinct, removable mass. This diffuse pattern of growth makes these tumors particularly challenging to treat surgically, as there are no clear boundaries between tumor and healthy brain tissue.[7]

As a brainstem glioma grows, it occupies more space within the rigid confines of the skull. Since the skull cannot expand to accommodate the growing tumor, the pressure inside the head gradually increases. This intracranial pressure can lead to headaches that are typically worse in the morning and improve as the day progresses. Patients may also experience nausea and vomiting, particularly upon waking. In some cases, the tumor can block the normal flow of cerebrospinal fluid—the clear liquid that cushions the brain and spinal cord—leading to a condition called hydrocephalus, which further increases pressure inside the skull.[4]

Without treatment, the tumor continues to interfere with increasingly critical functions. The brainstem controls breathing, heart rate, blood pressure, swallowing, and many other automatic processes that keep the body functioning. As these control centers become progressively affected, patients face increasingly serious health challenges that can ultimately become life-threatening.[4]

Possible Complications

Brain stem glioma can lead to numerous complications, both from the tumor itself and from the treatments used to control it. Being aware of these potential complications helps patients and families prepare and respond appropriately when challenges arise.

One of the most concerning complications involves the tumor’s effect on the cranial nerves, which emerge from the brainstem to control facial sensation, eye movement, hearing, taste, and swallowing. Damage to these nerves can result in double vision, facial weakness or numbness, difficulty swallowing, changes in speech, and problems with balance and coordination. These complications can develop gradually or appear suddenly as the tumor grows or shifts position.[1]

Swallowing difficulties, known medically as dysphagia, present particular risks. When patients cannot swallow safely, food or liquids may enter the airway instead of the esophagus, leading to choking or aspiration pneumonia—a serious lung infection caused by inhaling foreign material. Some patients may require a feeding tube to ensure adequate nutrition and hydration while protecting their airway.[4]

Breathing problems can occur when the tumor affects the respiratory control centers in the brainstem. In severe cases, patients may need mechanical ventilation support to maintain adequate oxygen levels. This complication represents one of the most serious risks associated with brainstem gliomas, particularly those located in the medulla, where the respiratory centers are located.[4]

Hydrocephalus, the buildup of cerebrospinal fluid, occurs when the tumor blocks the natural pathways through which this fluid normally flows. The resulting increase in pressure can cause severe headaches, nausea, vomiting, drowsiness, and confusion. If not addressed promptly, hydrocephalus can lead to permanent brain damage. Treatment may involve surgically placing a shunt to drain the excess fluid or performing a procedure to create an alternative drainage pathway.[4]

Seizures can develop in some patients with brainstem glioma, particularly if the tumor spreads to other areas of the brain. These sudden bursts of abnormal electrical activity can cause convulsions, loss of consciousness, or temporary confusion. Seizures require prompt medical attention and often need to be managed with anti-seizure medications to prevent complications and improve quality of life.[9]

Treatment itself can also cause complications. Radiation therapy, while essential for controlling many brainstem gliomas, can damage healthy brain tissue surrounding the tumor, leading to fatigue, memory problems, and changes in thinking abilities. Chemotherapy commonly causes nausea, fatigue, hair loss, and a weakened immune system that increases vulnerability to infections. Steroids, often prescribed to reduce brain swelling, can lead to weight gain, mood changes, increased blood sugar levels, and greater susceptibility to infections.[9]

Emotional and cognitive changes represent another significant category of complications. The tumor’s location and the treatments used can affect personality, memory, concentration, and emotional regulation. Patients may experience mood swings, depression, anxiety, difficulty processing information, or changes in their fundamental personality traits. These changes can be deeply distressing for both patients and their loved ones.[19]

Impact on Daily Life

Living with brain stem glioma profoundly affects many aspects of daily life, extending far beyond physical symptoms to touch emotional well-being, relationships, work, and personal identity. Understanding these impacts helps patients and families develop realistic expectations and effective coping strategies.

Physical limitations often become the most immediately noticeable challenge. Balance problems and weakness can make walking difficult or dangerous, increasing the risk of falls. Simple tasks like buttoning a shirt, writing, or holding utensils may require more focus and effort than before. Some patients report that every little activity feels harder, demanding more concentration and energy than it once did. These changes in dexterity and coordination can affect independence and require adaptations in how daily tasks are accomplished.[20]

Vision changes, including double vision or problems with eye movement, can make reading, watching television, or driving impossible or unsafe. Facial weakness may affect not only eating and drinking but also the ability to express emotions through facial expressions, which can impact social interactions and self-image. Speech difficulties can frustrate attempts at communication, leaving patients feeling isolated or misunderstood.[1]

Cognitive changes pose their own set of challenges. Memory problems may make it difficult to remember appointments, conversations, or important information. Concentration difficulties can interfere with reading, following complex instructions, or managing household finances. Some patients find that they process information more slowly than before, requiring more time to understand and respond to situations. These cognitive changes can be particularly frustrating for people who previously prided themselves on their mental sharpness.[20]

Fatigue is nearly universal among brain tumor patients, often described as an overwhelming exhaustion that doesn’t improve with rest. This persistent tiredness can make it difficult to maintain normal activity levels, forcing patients to prioritize carefully and accept that they cannot do everything they once did. Simple outings may require rest periods before and after, and returning to work full-time may not be possible.[25]

Emotional and psychological impacts can be just as challenging as physical symptoms. Many patients experience anxiety about their diagnosis and uncertain future. Depression is common, arising from the losses associated with the illness—loss of independence, abilities, roles, and certainty about the future. Personality changes caused by the tumor or its treatment can be deeply unsettling, making patients feel as if they’re losing themselves or becoming someone they don’t recognize.[19]

⚠️ Important
Coping with the changes brought by brain stem glioma requires patience with yourself and willingness to ask for help. Many patients find that connecting with counselors, joining support groups, and learning mindfulness techniques helps them navigate the emotional challenges. It’s important to avoid turning to alcohol or drugs to cope with physical or emotional pain, as these can worsen your condition and interfere with treatment.

Work and financial concerns add additional stress. Many patients cannot continue working at their previous capacity, leading to reduced income at a time when medical expenses are mounting. Even those with good health insurance may struggle with copayments, deductibles, and costs not covered by insurance. The financial burden can create anxiety and force difficult decisions about treatment priorities and family resources.[19]

Relationships undergo significant strain and transformation. Family members and friends may not know how to help or what to say, sometimes withdrawing when support is most needed. Romantic partnerships must adapt to changing roles and abilities, with healthy partners taking on more caregiving responsibilities. Parents with brain stem glioma worry about their children’s well-being and struggle with being unable to fulfill their parenting roles as before. Children diagnosed with brainstem glioma face disruptions to their education, friendships, and normal developmental milestones.[19]

Despite these profound challenges, many patients find ways to adapt and maintain quality of life. Occupational therapists can suggest modifications and assistive devices that help maintain independence. Physical therapy can address balance and mobility issues, reducing fall risk. Speech therapy may help with swallowing and communication difficulties. Cognitive rehabilitation can provide strategies for compensating for memory and concentration problems. Learning to take each day as it comes, celebrating small victories, and focusing on what remains possible rather than what has been lost helps many patients find meaning and even moments of joy despite their diagnosis.[19][21]

Support for Families and Clinical Trial Participation

Families play a crucial role in supporting patients with brain stem glioma, particularly when it comes to exploring treatment options including participation in clinical trials. Understanding what clinical trials are, why they matter, and how to find appropriate opportunities empowers families to be effective advocates for their loved ones.

Clinical trials are research studies that test new treatments, medications, or approaches to care. For brainstem glioma patients, particularly those with aggressive tumors like DIPG, clinical trials may represent the most promising treatment options. Standard treatments for some types of brainstem glioma have shown limited effectiveness, making participation in research studies that evaluate innovative therapies especially important.[3]

Families should understand that clinical trials are carefully designed and closely monitored to protect participants’ safety while gathering information about new treatments. Before enrolling, patients and families receive detailed information about what the trial involves, potential risks and benefits, and what participation will require. This process, called informed consent, ensures that families can make educated decisions about whether a particular trial is right for their situation.[13]

Finding appropriate clinical trials requires active searching and advocacy. Families can start by asking their medical team about available trials. Many major cancer centers and children’s hospitals have staff dedicated to helping patients find and enroll in appropriate clinical studies. Online databases maintained by organizations like the National Cancer Institute allow families to search for trials based on diagnosis, location, and other factors. Some advocacy organizations also maintain listings of current trials and can help families understand their options.[3]

When considering a clinical trial, families should ask detailed questions about what participation involves. Important topics include the trial’s purpose, what treatments or procedures will be required, how often visits will be needed, potential side effects, whether participants can continue receiving the trial treatment if it appears helpful, and what happens if the disease progresses during the trial. Understanding these details helps families weigh the potential benefits against the commitments and risks involved.[13]

Practical support is equally important. Families can help by maintaining detailed records of symptoms, medications, and medical appointments. This information becomes invaluable during medical consultations and when considering whether to adjust treatment approaches. Transportation to appointments, help with daily tasks, emotional support during difficult moments, and simply being present all provide essential support that helps patients cope with their diagnosis and treatment.[19]

Emotional support involves more than just being physically present. It means listening without judgment, acknowledging the patient’s fears and frustrations, and providing reassurance while respecting the seriousness of the situation. For children with brainstem glioma, families must balance honesty with age-appropriate information, maintaining as much normalcy as possible while accommodating necessary medical care. Siblings may need their own support as family attention necessarily focuses on the patient.[19]

Financial advocacy represents another crucial family role. This might involve researching insurance coverage, appealing denied claims, exploring financial assistance programs offered by hospitals or nonprofit organizations, or helping with applications for disability benefits. Many families benefit from speaking with hospital social workers who can identify resources and assistance programs.[19]

Families should also recognize their own needs for support. Caring for someone with a serious illness is physically and emotionally exhausting. Caregiver support groups, counseling, respite care arrangements that allow brief breaks, and maintaining some personal activities and relationships all help prevent caregiver burnout. Taking care of oneself isn’t selfish—it’s essential for being able to provide sustained support to the patient.[19]

Looking ahead, families can help by discussing the patient’s wishes regarding care decisions, particularly if the disease progresses. While these conversations are difficult, having them while the patient can still communicate clearly ensures that care aligns with their values and preferences. Documenting these wishes through advance directives provides clarity and reduces stress during emotionally challenging times.[19]

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Temozolomide (Temodar) – An oral chemotherapy medication taken once daily, commonly used for treating high-grade brainstem gliomas, particularly those with glioblastoma histology
  • Dordaviprone (Modeyso) – Approved in August 2025 by the FDA for treatment of diffuse midline glioma harboring an H3 K27M mutation in adults and pediatric patients aged 1 year and older who have progressive disease following prior therapy
  • Carboplatin – A conventional chemotherapy agent that may be used in combination with other drugs for treating brainstem gliomas
  • Vincristine – A conventional chemotherapy agent often used in combination with carboplatin for brainstem glioma treatment
  • Bevacizumab – An antiangiogenesis agent used with variable success in brainstem gliomas
  • Thalidomide – An antiangiogenesis agent that has been used in some brainstem glioma cases
  • Topotecan – A chemotherapy drug that has been investigated for use in brainstem glioma treatment
  • Corticosteroids (such as Decadron) – Steroids used to treat brain swelling and reduce intracranial pressure, though they can cause side effects including weight gain and increased infection risk

Ongoing Clinical Trials on Brain stem glioma

  • Study on ONC201 and Everolimus with Radiotherapy for Newly Diagnosed Diffuse Intrinsic Pontine Glioma and Other Diffuse Midline Gliomas in Children, Adolescents, and Adults

    Recruiting

    1 1 1 1
    Investigated diseases:
    Denmark France Spain Sweden
  • Testing the Safety of Dendritic Cell and CAR-T Cell Combination Therapy in Patients with Newly Diagnosed Diffuse Intrinsic Pontine Glioma

    Not yet recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Spain
  • Study on ONC201 and Paxalisib for Children and Young Adults with Diffuse Midline Gliomas, Including Diffuse Intrinsic Pontine Gliomas

    Not yet recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Study of WT1 LAMP mRNA DC Immunotherapy for Children with High-Grade Glioma and Diffuse Intrinsic Pontine Glioma

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Belgium
  • Study on Radiotherapy with Nimotuzumab and Vinorelbine for Newly Diagnosed Childhood and Adolescent Diffuse Intrinsic Pontine Glioma (DIPG) Patients

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

References

https://braintumorcenter.ucsf.edu/condition/brainstem-glioma

https://braintumourresearch.org/pages/types-of-brain-tumours-brainstem-glioma?srsltid=AfmBOorfanzKZoE0OuDGe7AxG4rt0Q3em4EdLmelmZ_oPneNSbJgw9r1

https://emedicine.medscape.com/article/1156030-overview

https://www.neurosurgery.columbia.edu/patient-care/conditions/brainstem-glioma

https://www.mayoclinic.org/diseases-conditions/glioma/symptoms-causes/syc-20350251

https://www.cancer.gov/publications/dictionaries/cancer-terms/def/brain-stem-glioma

https://cancer.ca/en/cancer-information/cancer-types/brain-and-spinal-cord-childhood/treatment/brain-stem-glioma

https://www.thebraintumourcharity.org/brain-tumour-diagnosis-treatment/types-brain-tumour-children/brainstem-glioma/

https://en.wikipedia.org/wiki/Brainstem_glioma

https://www.ncbi.nlm.nih.gov/books/NBK65812/

https://braintumorcenter.ucsf.edu/condition/brainstem-glioma

https://www.ncbi.nlm.nih.gov/books/NBK65856/

https://emedicine.medscape.com/article/1156030-treatment

https://www.mayoclinic.org/diseases-conditions/glioma/diagnosis-treatment/drc-20350255

https://www.neurosurgery.columbia.edu/patient-care/conditions/brainstem-glioma

https://www.ucsfbenioffchildrens.org/conditions/brainstem-glioma

https://www.cancer.gov/types/brain/hp/child-astrocytoma-glioma-treatment-pdq

https://umiamihealth.org/en/sylvester-comprehensive-cancer-center/treatments-and-services/brain-and-spine-tumors/brain-stem-glioma

https://www.ctbta.org/news/blog/overcoming-adversity-cope-brain-stem-tumor-prognosis

https://www.abta.org/mindmatters/thirty-tumor-how-a-brainstem-glioma-changed-my-life-and-gave-me-purpose/

https://www.mdanderson.org/cancerwise/brain-stem-tumor-survivor-take-it-one-day-at-a-time.h00-158990601.html

https://www.aaroncohen-gadol.com/en/patients/glioma/survival/end-of-life

https://www.thebraintumourcharity.org/brain-tumour-diagnosis-treatment/types-brain-tumour-children/brainstem-glioma/

https://braintumorcenter.ucsf.edu/condition/brainstem-glioma

https://braintumor.org/news/improving-balance-and-fall-prevention-for-patients-with-brain-tumors/

https://www.neurosurgeonsofnewjersey.com/blog/brain-stem-glioma-survival-rate-in-adults/

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

FAQ

Can brain stem glioma be cured?

For grade I focal brainstem gliomas, surgery alone can often be curative, and if complete removal isn’t possible, radiation therapy can be very effective as additional treatment. However, most brainstem gliomas are higher grade tumors that are much more difficult to cure. The outcome depends heavily on the tumor type, grade, and location.

Why can’t surgeons just remove brainstem gliomas?

The brainstem controls critical life functions like breathing, heart rate, and swallowing, and it’s packed with vital structures in a very small space. Many brainstem gliomas, particularly diffuse intrinsic pontine gliomas, spread throughout the tissue rather than forming a distinct removable mass, making surgery too dangerous as it could damage essential brain functions. However, some focal gliomas in safer locations can be surgically removed.

How quickly do symptoms develop with brainstem glioma?

This varies significantly by tumor type. High-grade aggressive tumors like DIPG can develop symptoms rapidly over days or weeks. Low-grade focal gliomas grow much more slowly, with symptoms developing gradually over months or even years. The speed of symptom development often provides clues about the tumor’s aggressiveness.

Are brainstem gliomas more common in children or adults?

Brainstem gliomas occur much more frequently in children, with most diagnoses occurring between ages 5 and 10. They constitute less than 2% of all gliomas in adults over age 16. Interestingly, when brainstem gliomas do occur in adults, they tend to be less aggressive and have better outcomes than pediatric cases.

Do I need a biopsy to diagnose brainstem glioma?

Often, an MRI scan alone can identify brainstem glioma and determine which area of the brainstem is affected. Historically, many brainstem gliomas were not biopsied. However, some centers now routinely perform biopsies to confirm the diagnosis and analyze tumor tissue for specific genetic features that may inform treatment decisions. Whether a biopsy is needed depends on your specific situation and your medical team’s recommendations.

🎯 Key takeaways

  • Brainstem gliomas behave very differently depending on their location—tumors in the midbrain and medulla are usually low-grade, while those in the pons are typically aggressive grade IV tumors
  • Adults with brainstem glioma generally have better outcomes than children, with average survival of 44-74 months compared to less than 18 months for children with DIPG
  • The brainstem’s small size and vital functions make surgery impossible or extremely risky for many brainstem gliomas, especially diffuse intrinsic pontine gliomas
  • Radiation therapy remains the cornerstone of treatment for most brainstem gliomas, with conventional doses ranging from 54 to 60 Gy considered standard
  • Molecular profiling has become essential for understanding prognosis, with certain genetic mutations like IDH1 significantly improving outcomes regardless of tumor grade
  • Clinical trials represent important treatment options, especially for aggressive tumors, and families should actively explore available research studies
  • Living with brainstem glioma affects not just physical abilities but also cognition, emotions, relationships, work, and financial stability—requiring comprehensive support strategies
  • The FDA approved the first targeted therapy (dordaviprone) specifically for H3 K27M-mutant diffuse midline glioma in August 2025, representing a significant advance in treatment options